Related references
Note: Only part of the references are listed.Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
Xing Huang et al.
MOLECULAR CANCER (2021)
Beyond immune checkpoint blockade: emerging immunological strategies
Shawn P. Kubli et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Ashish Manne et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical and immunological effects of mRNA vaccines in malignant diseases
Annkristin Heine et al.
MOLECULAR CANCER (2021)
Cholangiocarcinoma
Paul J. Brindley et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley et al.
JOURNAL OF HEPATOLOGY (2020)
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies
Sarina A. Piha-Paul et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Computational Prediction and Validation of Tumor-Associated Neoantigens
Vladimir Roudko et al.
FRONTIERS IN IMMUNOLOGY (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial
Oliver Klein et al.
JAMA ONCOLOGY (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
Xing Huang et al.
NPJ PRECISION ONCOLOGY (2020)
The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
Hao Chen et al.
ONCOIMMUNOLOGY (2019)
Tumor neoantigens: from basic research to clinical applications
Tao Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
Darin K. Edwards et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
TIMPs: versatile extracellular regulators in cancer
Hartland W. Jackson et al.
NATURE REVIEWS CANCER (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Hanna J. Khoury et al.
CANCER (2017)
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
John Bridgewater et al.
BMC CANCER (2016)
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
Markus W. Loeffler et al.
JOURNAL OF HEPATOLOGY (2016)
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Aleksandra Kowalczyk et al.
VACCINE (2016)
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
Jon Amund Kyte et al.
ONCOIMMUNOLOGY (2016)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2015)
Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
Asim Amin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
S. Pant et al.
ANNALS OF ONCOLOGY (2014)
Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
Shigeo Koido et al.
CLINICAL CANCER RESEARCH (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Koichi Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Share Paper
